The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from the Oura Ring. Combining glucose data with biometrics can deliver a more complete picture of overall health to users.
In addition to the collaboration, Dexcom announced a $75 million strategic investment in Oura’s Series D funding. The company said Oura is now valued at more than $5 billion.
“Dexcom offers the most accurate glucose biosensing systems on the market that help reveal the impact of daily lifestyle choices on glucose levels and enable our users to make informed decisions about their health and overall well-being,” said Matt Dolan, EVP of strategy and corporate development at Dexcom. “Partnering with Oura gives us the opportunity to redefine the category again, integrating data from Dexcom glucose biosensors with the continuous insights and metrics measured by Oura Ring. This powerful combination will attract new shared customers who want to better understand the link between activity, sleep, nutrition and their glucose.”
More details of this partnership
Under the agreement, Dexcom and Oura plan to launch integrations enabling data to flow between their products. That includes Dexcom glucose biosensors and apps, along with the Oura Ring and Oura App. With this integration, users can track glucose levels and understand the impact of behaviors and biology on their metabolic health.
Additionally, the companies intend to co-market and cross-sell each others’ products. They expect the first app integration to launch in the first half of 2025.
Dexcom continues to offer its leading CGM systems, along with Stelo, its recently launched over-the-counter glucose biosensor. Combining its OTC CGM offering with the retail-available Oura Ring further extends its reach beyond its prescription base.
Oura, meanwhile, continues accelerating its business, which reports more than 2.5 million rings sold. The company expects to see annual sales double in 2024 to roughly $500 million. Oura also recently introduced a “Meals” feature for users to track meal timing and see how what and when they eat can impact health. That aligns significantly with people monitoring their diabetes, as mealtime adjustments are a key part of managing the condition.
“Ninety-seven percent of Oura members have expressed interest in understanding how the food they eat impacts their health. This partnership with Dexcom will enable us to empower our members to make informed decisions and adjust behaviors to positively impact their biometrics and long-term health,” said Tom Hale, Oura CEO. “Working together, Oura and Dexcom will help members decide what and when to eat by surfacing correlations between activities like sleep and exercise and members’ glucose levels. And because we know that people are affected differently by the same foods and activities, guidance and insights will be personalized.”
